Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

Abroad (travel likely)Recruiting

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Cancer Hospital & Institute, Beijing, Haidian District, China
Contact: Study coordinator (Lin Wang, M.D.) · wanglinmd@foxmail.com · +8613910975011
Contact: Study coordinator (Xiaokang Lei, M.D.) · lxkpku@163.com · +8610-88196086
Contact: Principal Investigator (Lin Wang, M.D.)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Huntsville, United States · Fullerton, United States

Early Detection of Advanced Adenomas and Colorectal Cancer

Colorectal Cancer · Colorectal Neoplasms · Colorectal Polyp

Abroad (travel likely)Recruiting

Monrovia, United States · San Diego, United States

ColoSeal™ ICD System Safety and Feasibility Study

Colorectal Cancer

Abroad (travel likely)Recruiting

Yerevan, Armenia · Tbilisi, Georgia